Drug details
Methitest (methyltestosterone tablets, usp)
type of Androgens
Methitest (methyltestosterone) is an androgen, a male hormone, indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone such as primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired) in males, and to treat advancing inoperable metastatic (skeletal) mammary cancer in females who are 1 to 5 years postmenopausal.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- upper stomach pain,
- loss of appetite,
- itching,
- dark urine,
- clay-colored stools, and
- yellowing of the skin or eyes (jaundice)
- tiredness,
- swelling,
- rapid weight gain,
- acne,
- changes in menstrual periods,
- changes in skin color,
- increased or ongoing erection of the penis,
- shortness of breath (even with mild exertion),
- Development of male characteristics (in women):
- male-pattern hair growth (such as on the chin or chest),
- hoarse or deepened voice, and
- enlarged clitoris
The following drugs are related to Methitest, either as a replacement or used together:
- AndroGel (testosterone gel for topical use)
- AndroGel 1.62 (testosterone gel)
- Axiron (testosterone topical solution)
- Delatestryl (testosterone enanthate)
- EEMT (esterified estrogens and methyltestosterone tablets)
- Estratest (esterified estrogens and methyltestosterone)
- Fortesta (testosterone gel)
- Kyzatrex (testosterone undecanoate capsules)
- Testred (methyltestosterone)
- Striant (testosterone)
- Testim (testosterone gel)
- Testopel (testosterone pellets)
- Tlando (testosterone undecanoate capsules)